Acorah Software Products - Accounts Production 19.4.351 false true 31 October 2024 1 November 2023 false 1 November 2024 31 October 2025 31 October 2025 08101482 Mrs I Soltamova Solovyev Mr M Rossmann iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08101482 2024-10-31 08101482 2025-10-31 08101482 2024-11-01 2025-10-31 08101482 frs-core:CurrentFinancialInstruments 2025-10-31 08101482 frs-core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-11-01 2025-10-31 08101482 frs-core:OtherResidualIntangibleAssets 2025-10-31 08101482 frs-core:OtherResidualIntangibleAssets 2024-10-31 08101482 frs-core:PlantMachinery 2025-10-31 08101482 frs-core:PlantMachinery 2024-11-01 2025-10-31 08101482 frs-core:PlantMachinery 2024-10-31 08101482 frs-core:SharePremium 2025-10-31 08101482 frs-core:ShareCapital 2025-10-31 08101482 frs-core:RetainedEarningsAccumulatedLosses 2025-10-31 08101482 frs-bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 08101482 frs-bus:FilletedAccounts 2024-11-01 2025-10-31 08101482 frs-bus:SmallEntities 2024-11-01 2025-10-31 08101482 frs-bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 08101482 frs-bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 08101482 frs-core:CostValuation 2024-10-31 08101482 frs-core:DisposalsRepaymentsInvestments 2025-10-31 08101482 frs-core:CostValuation 2025-10-31 08101482 frs-core:ListedExchangeTraded 2025-10-31 08101482 frs-core:ListedExchangeTraded 2024-10-31 08101482 frs-core:CostValuation frs-core:ListedExchangeTraded 2024-10-31 08101482 frs-core:DisposalsRepaymentsInvestments frs-core:ListedExchangeTraded 2025-10-31 08101482 frs-core:CostValuation frs-core:ListedExchangeTraded 2025-10-31 08101482 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2024-10-31 08101482 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2025-10-31 08101482 frs-core:UnlistedNon-exchangeTraded 2025-10-31 08101482 frs-core:UnlistedNon-exchangeTraded 2024-10-31 08101482 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-10-31 08101482 frs-core:DisposalsRepaymentsInvestments frs-core:UnlistedNon-exchangeTraded 2025-10-31 08101482 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2025-10-31 08101482 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-10-31 08101482 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2025-10-31 08101482 frs-bus:Director1 2024-11-01 2025-10-31 08101482 frs-bus:Director2 2024-11-01 2025-10-31 08101482 frs-countries:EnglandWales 2024-11-01 2025-10-31 08101482 2023-10-31 08101482 2024-10-31 08101482 2023-11-01 2024-10-31 08101482 frs-core:CurrentFinancialInstruments 2024-10-31 08101482 frs-core:SharePremium 2024-10-31 08101482 frs-core:ShareCapital 2024-10-31 08101482 frs-core:RetainedEarningsAccumulatedLosses 2024-10-31
Registered number: 08101482
Cambridge Oncometrix Limited
Unaudited Financial Statements
For The Year Ended 31 October 2025
Cambridge Oncometrix Limited
3B Homefield Road
Haverhill
CB9 8QP
Contents
Page
Company Information 1
Statement of Financial Position 2—3
Notes to the Financial Statements 4—6
Page 1
Company Information
Directors Mrs I Soltamova Solovyev
Mr M Rossmann
Company Number 08101482
Registered Office 3B Homefield Road
Haverhill
CB9 8QP
Accountants Cambridge Oncometrix Limited
3B Homefield Road
Haverhill
CB9 8QP
Page 1
Page 2
Statement of Financial Position
Registered number: 08101482
2025 2024
Notes £ £ £ £
FIXED ASSETS
Intangible Assets 4 124,574 124,574
Tangible Assets 5 4,158 4,158
Investments 6 - 3,300
128,732 132,032
CURRENT ASSETS
Debtors 7 (56,708 ) (56,708 )
Cash at bank and in hand 3,076 4,396
(53,632 ) (52,312 )
Creditors: Amounts Falling Due Within One Year 8 (99,278 ) (96,348 )
NET CURRENT ASSETS (LIABILITIES) (152,910 ) (148,660 )
TOTAL ASSETS LESS CURRENT LIABILITIES (24,178 ) (16,628 )
NET LIABILITIES (24,178 ) (16,628 )
CAPITAL AND RESERVES
Called up share capital 9 7,324 7,324
Share premium account 145,443 145,443
Income Statement (176,945 ) (169,395 )
SHAREHOLDERS' FUNDS (24,178) (16,628)
Page 2
Page 3
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Income Statement.
The financial statements were approved by the board of directors on 10/10/2024 and were signed on its behalf by:
Mrs I Soltamova Solovyev
Director
01/10/2026
The notes on pages 4 to 6 form part of these financial statements.
Page 3
Page 4
Notes to the Financial Statements
1. General Information
Cambridge Oncometrix Limited is a private company, limited by shares, incorporated in England & Wales, registered number 08101482 . The registered office is 3B Homefield Road, Haverhill, CB9 8QP.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Intangible Fixed Assets and Amortisation - Other Intangible
Other intangible assets are .... It is amortised to the income statement over its estimated economic life of .... years.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 10
2.5. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
4. Intangible Assets
Other
£
Cost
As at 1 November 2024 124,574
As at 31 October 2025 124,574
Net Book Value
As at 31 October 2025 124,574
As at 1 November 2024 124,574
Page 4
Page 5
5. Tangible Assets
Plant & Machinery
£
Cost
As at 1 November 2024 4,158
As at 31 October 2025 4,158
Net Book Value
As at 31 October 2025 4,158
As at 1 November 2024 4,158
Included above are assets held under finance leases or hire purchase contracts with a net book value as follows:
6. Investments
Listed Unlisted Total
£ £ £
Cost or Valuation
As at 1 November 2024 - 3,300 3,300
Disposals (3,300 ) - (3,300 )
As at 31 October 2025 (3,300 ) 3,300 -
Provision
As at 1 November 2024 - - -
As at 31 October 2025 - - -
Net Book Value
As at 31 October 2025 (3,300 ) 3,300 -
As at 1 November 2024 - 3,300 3,300
7. Debtors
2025 2024
£ £
Due within one year
Trade debtors 11,194 11,194
Prepayments and accrued income (67,902 ) (67,902 )
(56,708 ) (56,708 )
Page 5
Page 6
8. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Trade creditors 51,044 51,044
Bank loans and overdrafts 34,835 31,255
VAT 961 961
Net wages 8,058 8,708
Directors' loan accounts 4,380 4,380
99,278 96,348
9. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 7,324 7,324
Page 6